{"meta":{"query_hash":"b7b02f73b86d","filters":{"venue":"Journal of Commercial Biotechnology"},"cohort_total":20,"direct_labels_cover":0,"predictions_cover":20,"exported":20,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b7b02f73b86d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Commercial+Biotechnology"},"results":[{"id":"W1550526788","doi":"10.5912/jcb711","title":"The Globetrotting Regulator","year":2015,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fraternity; Government (linguistics); Battle; China; Health care; Politics; Political science; Economic growth; Public administration; Law; Economics; History; Ancient history","score_opus":0.08344887446268374,"score_gpt":0.2980808370679797,"score_spread":0.214631962605296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1550526788","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016117139,0.0071082283,0.0022160592,0.46763334,0.029934872,0.000058920174,0.000566229,0.00049328106,0.4903773],"genre_scores_gemma":[0.022892071,0.005286667,0.0014239867,0.23603944,0.0043065227,0.000090825604,0.00043827816,0.0003244006,0.72919774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947996,0.00065758213,0.00013401102,0.0010658298,0.0024260373,0.00091700867],"domain_scores_gemma":[0.9950958,0.0008284666,0.00023411335,0.0005999852,0.0021940072,0.0010476445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004995343,0.00074675836,0.0004960721,0.0008987598,0.0048301523,0.013598963,0.0014335008,0.014803013,0.0652124],"category_scores_gemma":[0.015253498,0.00038086815,0.0008872506,0.001308893,0.0036526916,0.008482436,0.0034890482,0.014243359,0.024966022],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015517135,0.000013571692,0.00017146402,0.000020661939,0.0000030494207,0.000053648466,0.00010155255,0.000055575463,0.0001497914,0.1620152,0.8269815,0.010418503],"study_design_scores_gemma":[0.000004670376,0.0000067225706,0.00015060186,0.00004426973,0.0000019674674,0.000022029431,0.00009451651,0.0000650035,0.00008791544,0.0071450206,0.9923694,0.000007937246],"about_ca_topic_score_codex":0.017325666,"about_ca_topic_score_gemma":0.015990933,"teacher_disagreement_score":0.0652124,"about_ca_system_score_codex":0.004569665,"about_ca_system_score_gemma":0.0162848,"threshold_uncertainty_score":0.21815723},"labels":[],"label_agreement":null},{"id":"W1589071603","doi":"10.5912/jcb652","title":"Staking an Advantage in an AIA World: Practical Patent Tips for Biotechnology Companies","year":2014,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Patentable subject matter; Investor relations; Subject matter; Bioethics; Patent law; Competitive advantage; Key (lock); Patentability; Business; Subject (documents); Biotechnology; Intellectual property; Invention; Law and economics; Law; Economics; Marketing; Strategic management; Political science; Computer science; Biology; World Wide Web; Computer security","score_opus":0.21060378146837744,"score_gpt":0.31663379071854364,"score_spread":0.1060300092501662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589071603","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007895307,0.021259714,0.028417464,0.80981904,0.003761661,0.00017403514,0.000075324206,0.0009050511,0.1276924],"genre_scores_gemma":[0.48031208,0.097888194,0.16183123,0.15677623,0.014710027,0.00066908053,0.00037033818,0.0004916732,0.086951226],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924676,0.002199546,0.00046781983,0.00053056696,0.0033252803,0.0010092196],"domain_scores_gemma":[0.97717035,0.013651292,0.0017352599,0.0017316048,0.0034808067,0.0022307395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016073843,0.0009030772,0.00057226425,0.002929487,0.006564495,0.014841916,0.0022507021,0.013949512,0.01518293],"category_scores_gemma":[0.035246793,0.00056530285,0.0006415536,0.0019577257,0.0092198225,0.034444906,0.0057335617,0.013784839,0.004249624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006109052,0.00029361923,0.0006069184,0.00026777489,0.0000079907595,0.00057417864,0.0017475632,0.00090647565,0.0009087816,0.48196796,0.19054003,0.32211757],"study_design_scores_gemma":[0.000054408683,0.00017465025,0.001114523,0.0007425737,0.000012674445,0.00069061544,0.004498724,0.0010648519,0.0008527069,0.43067855,0.56000316,0.000112496826],"about_ca_topic_score_codex":0.0020323417,"about_ca_topic_score_gemma":0.003707473,"teacher_disagreement_score":0.016073843,"about_ca_system_score_codex":0.0036563238,"about_ca_system_score_gemma":0.010109953,"threshold_uncertainty_score":0.08500761},"labels":[],"label_agreement":null},{"id":"W1998219596","doi":"10.1057/jcb.2008.17","title":"Networks of dedicated biotechnology and service firms in Vancouver","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation and Knowledge Management","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University","funders":"Simon Fraser University","keywords":"Embeddedness; Competitor analysis; Service (business); Business; Key (lock); Industrial organization; Marketing; Sociology; Computer science; Computer security","score_opus":0.01737890348448996,"score_gpt":0.22048751931760632,"score_spread":0.20310861583311637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998219596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989277,0.00039309773,0.00015763163,0.00030714966,0.000003795567,0.000031964028,0.00041236085,0.0000075985254,0.009409452],"genre_scores_gemma":[0.99471635,0.00042401714,0.00018317068,0.000043915,0.0000013907248,0.0000144369915,0.00039425018,0.0000030034728,0.0042195763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990563,0.00013894099,0.00003604874,0.00014741524,0.00025142365,0.00036984912],"domain_scores_gemma":[0.9970811,0.00049060537,0.00045151537,0.00008396639,0.0009155634,0.000977104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046744943,0.00014902906,0.00023684901,0.0026634943,0.0035877712,0.00255743,0.00072344317,0.0005454583,0.0034879078],"category_scores_gemma":[0.0038954497,0.00026294985,0.000096281736,0.0057155113,0.0010616867,0.0007042563,0.0024525847,0.0002823825,0.00037973808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041297343,0.00012928715,0.8459419,0.00021072131,0.000060658454,0.0019964864,0.043010913,0.0030808637,0.002808992,0.009280168,0.0053723454,0.08769471],"study_design_scores_gemma":[0.000027478416,0.00006121106,0.8942978,0.00010566554,0.000027231625,0.00047283852,0.07396516,0.0031721664,0.00062412303,0.001185885,0.02601284,0.00004759563],"about_ca_topic_score_codex":0.94252807,"about_ca_topic_score_gemma":0.96512425,"teacher_disagreement_score":0.05747193,"about_ca_system_score_codex":0.0176566,"about_ca_system_score_gemma":0.0125536,"threshold_uncertainty_score":0.1281082},"labels":[],"label_agreement":null},{"id":"W2007032324","doi":"10.1057/palgrave.jcb.3050087","title":"Risk management for the biotechnology industry: A Canadian perspective","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk management; Business; New product development; Strategic planning; Order (exchange); Position (finance); Enterprise risk management; Corporate governance; Product (mathematics); Market risk; Profit (economics); Industrial organization; Finance; Marketing; Economics","score_opus":0.0166169519568604,"score_gpt":0.27076712544454595,"score_spread":0.25415017348768554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007032324","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023101743,0.10403391,0.014139624,0.5067223,0.0017704476,0.00012091257,0.0004900685,0.0001267518,0.34949434],"genre_scores_gemma":[0.66331303,0.19168426,0.022026569,0.0314522,0.0012191532,0.00007790977,0.00034282688,0.00010195517,0.08978215],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99513763,0.00089532055,0.00017383715,0.00034397445,0.0024235426,0.0010257903],"domain_scores_gemma":[0.9920048,0.0014287324,0.00047437774,0.00015275943,0.00435452,0.0015848206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004499843,0.0010460295,0.00054405484,0.004694657,0.010759253,0.011001378,0.002422061,0.004036745,0.005602723],"category_scores_gemma":[0.007496103,0.00039793664,0.0009168054,0.0044321823,0.008345259,0.0038674194,0.0024747576,0.0042735673,0.0004872088],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000569121,0.00009214218,0.006011429,0.0005548613,0.000042114334,0.0010417472,0.008482834,0.0072047524,0.000861076,0.7858921,0.094658345,0.09510149],"study_design_scores_gemma":[0.000023033648,0.000063484134,0.010591746,0.0014335702,0.000082432634,0.00068365206,0.01575517,0.006426608,0.0006733685,0.153594,0.8104568,0.00021619185],"about_ca_topic_score_codex":0.9749094,"about_ca_topic_score_gemma":0.9716086,"teacher_disagreement_score":0.82538307,"about_ca_system_score_codex":0.17461695,"about_ca_system_score_gemma":0.23782103,"threshold_uncertainty_score":0.95732737},"labels":[],"label_agreement":null},{"id":"W2014084367","doi":"10.5912/jcb645","title":"Market Orientation, Alliance Orientation, and Business Performance in the Biotechnology Industry","year":2014,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation and Knowledge Management","field":"Business, Management and Accounting","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Alliance; Commercialization; Market orientation; Business; Mediation; Marketing; Biotechnology; Business administration; Industrial organization; Biology; Sociology","score_opus":0.01374928068249951,"score_gpt":0.24031212292133003,"score_spread":0.22656284223883053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014084367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926617,0.00012913563,0.000043808115,0.00019366726,0.0000034353309,0.000008073179,0.000026215788,0.000001813112,0.0069321683],"genre_scores_gemma":[0.9991616,0.00010431313,0.000050695333,0.0000295973,0.0000036429312,0.0000030558392,0.00003976406,9.998191e-7,0.0006063981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991598,0.00013674905,0.000019966314,0.000033688284,0.0004280878,0.0002216409],"domain_scores_gemma":[0.99397993,0.0008860009,0.0017622358,0.000075126336,0.000896282,0.0024004537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013036571,0.00019280921,0.00011577661,0.0016504955,0.0012746748,0.0018782013,0.00026810018,0.00031000728,0.0026954827],"category_scores_gemma":[0.003970525,0.0000807666,0.00014821082,0.001395121,0.0010479365,0.000482386,0.00084823393,0.00059946073,0.000158627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064050684,0.0002800638,0.98454845,0.000018359633,0.000029227602,0.00007039733,0.0014051491,0.000112526686,0.00042945924,0.0011008901,0.00035277067,0.011588628],"study_design_scores_gemma":[0.0000027561011,0.000039765542,0.99665016,0.0000103651355,0.000007180014,0.00001618694,0.002375823,0.000124598,0.00006238744,0.0001395659,0.0005668044,0.0000042879137],"about_ca_topic_score_codex":0.33962977,"about_ca_topic_score_gemma":0.5352084,"teacher_disagreement_score":0.33962977,"about_ca_system_score_codex":0.004638826,"about_ca_system_score_gemma":0.0076659215,"threshold_uncertainty_score":0.67530584},"labels":[],"label_agreement":null},{"id":"W2025816121","doi":"10.1057/palgrave.jcb.3040051","title":"What will it take to get institutional investors interested in life sciences again?","year":2003,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada","funders":"","keywords":"Investor relations; Appeal; Business; Institutional investor; State (computer science); Accounting; Strategic management; Marketing; Finance; Political science; Corporate governance; Law","score_opus":0.03381963124527491,"score_gpt":0.3068567244523679,"score_spread":0.27303709320709296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025816121","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027180081,0.017001644,0.001082294,0.96458036,0.00505023,0.000037906375,0.000052732084,0.000081791375,0.00939503],"genre_scores_gemma":[0.16610177,0.1303318,0.012896064,0.6229698,0.027621174,0.0006751173,0.00030837578,0.00018185009,0.03891404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927973,0.002473892,0.00034596614,0.00035851146,0.0020014613,0.0020229134],"domain_scores_gemma":[0.9551644,0.010492537,0.003944658,0.0009087045,0.007889445,0.021600325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021167975,0.0007298086,0.0009190063,0.0016196204,0.005122154,0.018082026,0.0016741075,0.022185894,0.017739],"category_scores_gemma":[0.040487085,0.00037717397,0.0010153562,0.0009067541,0.00561533,0.0168411,0.0032100237,0.008759615,0.008759963],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055939757,0.0009247214,0.009209489,0.0018280643,0.00012852211,0.00085742836,0.0011158983,0.0005377198,0.0011168559,0.059153985,0.48400635,0.44056168],"study_design_scores_gemma":[0.00034472145,0.001331235,0.021539064,0.0056317723,0.00018987119,0.0028747632,0.022126472,0.0012242727,0.0024900793,0.1407552,0.80117637,0.00031623934],"about_ca_topic_score_codex":0.004412239,"about_ca_topic_score_gemma":0.006983628,"teacher_disagreement_score":0.022185894,"about_ca_system_score_codex":0.0050438317,"about_ca_system_score_gemma":0.013797382,"threshold_uncertainty_score":0.11194831},"labels":[],"label_agreement":null},{"id":"W2028247102","doi":"10.5912/jcb649","title":"Canadian Venture Capital - Unlocking the Funding Challenge","year":2014,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Private Equity and Venture Capital","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venture capital; Social venture capital; Business; Government (linguistics); Finance; Entrepreneurship; Seed money; New Ventures","score_opus":0.016499741728111854,"score_gpt":0.21976204990614884,"score_spread":0.20326230817803698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028247102","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008583658,0.016079556,0.0021469155,0.79200983,0.005091907,0.00007416248,0.00070028414,0.00019032111,0.17512329],"genre_scores_gemma":[0.4766293,0.048404064,0.011443995,0.15705696,0.0067039733,0.00021293573,0.00139517,0.0004071159,0.29774648],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9836955,0.0012733162,0.00031940464,0.0008343265,0.010748613,0.0031287973],"domain_scores_gemma":[0.9545463,0.0072222576,0.0011759019,0.0014610211,0.021433348,0.014161128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010872052,0.00053676224,0.00066867116,0.0037217827,0.011577068,0.018625636,0.002762045,0.009910076,0.014952491],"category_scores_gemma":[0.049318526,0.00049757573,0.0005714113,0.004318982,0.0056538437,0.006271067,0.0047739237,0.0073637967,0.0016631561],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000413158,0.000016442316,0.0011434121,0.00012039883,0.000013352626,0.00033263417,0.00067676895,0.0003675981,0.0002236382,0.473867,0.4697401,0.053457342],"study_design_scores_gemma":[0.000027225828,0.000012418783,0.0020965773,0.0002286148,0.000009669931,0.00009360525,0.00056416186,0.00065272884,0.00012911651,0.033659406,0.9624856,0.00004079666],"about_ca_topic_score_codex":0.9447025,"about_ca_topic_score_gemma":0.9622857,"teacher_disagreement_score":0.082554325,"about_ca_system_score_codex":0.082554325,"about_ca_system_score_gemma":0.25724068,"threshold_uncertainty_score":0.5989764},"labels":[],"label_agreement":null},{"id":"W2053826437","doi":"10.1057/jcb.2011.26","title":"Catalyzing capital for Canada's life sciences industry","year":2011,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Private Equity and Venture Capital","field":"Business, Management and Accounting","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Investor relations; Bioethics; Business; Capital (architecture); Strategic management; Economics; Management; Political science; Marketing; Geography","score_opus":0.04632110799597593,"score_gpt":0.24183735550165678,"score_spread":0.19551624750568086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053826437","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74011254,0.0014050144,0.002693995,0.01988836,0.00010060538,0.00054737646,0.0016752474,0.00018034084,0.23339655],"genre_scores_gemma":[0.97749,0.00046404998,0.0019607258,0.0010236924,0.000013778264,0.000037596383,0.00037773582,0.000009296312,0.018623112],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982595,0.0001493111,0.000023804401,0.00008701261,0.0005557411,0.00092467916],"domain_scores_gemma":[0.9957722,0.0006883042,0.00038130945,0.00018462676,0.0012003247,0.0017733044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013565343,0.00027497482,0.0001809268,0.0011876316,0.004930444,0.0044125677,0.0006584134,0.00092652434,0.0056228884],"category_scores_gemma":[0.0053654867,0.00016726187,0.00023948903,0.0009388608,0.0015918935,0.00091773964,0.0017968033,0.0012083828,0.0003001358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007787877,0.0007588654,0.31173775,0.00070381165,0.00016475849,0.0011066663,0.0065777684,0.010922639,0.010932438,0.30667177,0.10840229,0.24124257],"study_design_scores_gemma":[0.00027572768,0.00030802353,0.45649427,0.0004686177,0.000217883,0.00027117916,0.012789279,0.011199794,0.0127952,0.019225203,0.48582768,0.00012710238],"about_ca_topic_score_codex":0.9739751,"about_ca_topic_score_gemma":0.9904169,"teacher_disagreement_score":0.92461157,"about_ca_system_score_codex":0.0753884,"about_ca_system_score_gemma":0.18005879,"threshold_uncertainty_score":0.5469837},"labels":[],"label_agreement":null},{"id":"W2057868875","doi":"10.1057/jcb.2008.16","title":"A comparison of R&D indicators for the Vancouver biotechnology cluster","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Investor relations; Bioethics; Cluster (spacecraft); Biotechnology; Business; Strategic management; Economics; Political science; Marketing; Biology; Computer science; Law","score_opus":0.08105818552773462,"score_gpt":0.3141772405014212,"score_spread":0.23311905497368657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057868875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93091077,0.0010003356,0.0015598511,0.0005966157,0.000015940104,0.0001378581,0.008853056,0.00011956548,0.056805942],"genre_scores_gemma":[0.98725176,0.00042802334,0.0011547839,0.000030911368,0.0000043983314,0.000037679754,0.0055811,0.000024263027,0.00548719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974366,0.00029712872,0.00015283182,0.00022731432,0.0014129884,0.0004732548],"domain_scores_gemma":[0.98455805,0.0021762913,0.0020792475,0.00067998207,0.00872401,0.0017823084],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.0015530547,0.0003212319,0.00043143446,0.010915848,0.00089866045,0.0035685706,0.00072972965,0.00032984282,0.0020864299],"category_scores_gemma":[0.010940949,0.00021430194,0.00023788624,0.019178577,0.00069895305,0.00055194704,0.0021785798,0.00049448444,0.00040363334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005479656,0.00006642203,0.904934,0.00025045572,0.00014091613,0.00022898702,0.0016189514,0.007598355,0.0016163335,0.008411174,0.005018285,0.06956813],"study_design_scores_gemma":[0.000014357612,0.000046465855,0.98246735,0.000030206884,0.00002226681,0.00004687471,0.0019814193,0.0023524028,0.0008831334,0.0005228528,0.011608076,0.000024650592],"about_ca_topic_score_codex":0.72202057,"about_ca_topic_score_gemma":0.82113177,"teacher_disagreement_score":0.9890841,"about_ca_system_score_codex":0.015270425,"about_ca_system_score_gemma":0.010756031,"threshold_uncertainty_score":0.559233},"labels":[],"label_agreement":null},{"id":"W2080277760","doi":"10.1057/jcb.2008.19","title":"Connecting product innovation management and marketing","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Business Strategy and Innovation","field":"Business, Management and Accounting","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Investor relations; Business; Marketing; Product (mathematics); Marketing management; Product management; Strategic management; Product strategy; New product development","score_opus":0.027292386017886923,"score_gpt":0.23310330541497049,"score_spread":0.20581091939708357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080277760","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14981756,0.021071764,0.03455738,0.12738787,0.0012617214,0.000071137096,0.00010320304,0.00014471544,0.66558474],"genre_scores_gemma":[0.9705549,0.005913191,0.003769483,0.0023559514,0.0011369404,0.00003257993,0.000033111588,0.000025031577,0.016178813],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99830186,0.0008804963,0.000054826512,0.00013707706,0.00043267873,0.0001929192],"domain_scores_gemma":[0.9897106,0.0070461845,0.0012893967,0.00034960816,0.0009787086,0.00062548945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002372613,0.0002575446,0.00022968273,0.002496533,0.001187164,0.0075952807,0.00048543478,0.0024769055,0.014624258],"category_scores_gemma":[0.009056676,0.00028186847,0.00017442339,0.0023646634,0.0033996613,0.006499027,0.0013402732,0.0015781664,0.0011103172],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070838156,0.00034878438,0.019520087,0.0002119509,0.00004295433,0.00015182461,0.0020592257,0.0015736432,0.0007513716,0.68535525,0.01869906,0.27121508],"study_design_scores_gemma":[0.000020255746,0.00009360385,0.029513035,0.00031799352,0.000041788717,0.00019288828,0.004351149,0.0060279085,0.0011775971,0.85484034,0.10338713,0.000036304067],"about_ca_topic_score_codex":0.0013504783,"about_ca_topic_score_gemma":0.0021335476,"teacher_disagreement_score":0.014624258,"about_ca_system_score_codex":0.002369271,"about_ca_system_score_gemma":0.002405614,"threshold_uncertainty_score":0.048923075},"labels":[],"label_agreement":null},{"id":"W2090438504","doi":"10.5912/jcb660","title":"To Market, To Market: Ontario, Canada’s vision to improve commercialization of healthcare research","year":2014,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Commercialization; Government (linguistics); Investment (military); Business; Market analysis; Incentive; Seed money; Finance; Capital market; Health care; Investor relations; Bioethics; Venture capital; Marketing; Economic growth; Strategic management; Economics; Market economy; Political science","score_opus":0.04601344928933147,"score_gpt":0.325259145699664,"score_spread":0.27924569641033253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090438504","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01137184,0.015153634,0.0046682954,0.8339633,0.0028122873,0.00026586503,0.0027756928,0.00038635166,0.12860277],"genre_scores_gemma":[0.25374755,0.035963878,0.03806135,0.1455212,0.0023846594,0.0004981585,0.0030243455,0.00037033312,0.52042854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99371135,0.0006725835,0.00017467704,0.00036711956,0.0038599675,0.0012142515],"domain_scores_gemma":[0.97767544,0.0019318863,0.0010541014,0.00066196395,0.009918717,0.008757892],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008906891,0.00051938754,0.00035335033,0.0015460793,0.0055907597,0.009371606,0.0016592424,0.00557105,0.008375142],"category_scores_gemma":[0.011967602,0.0005157583,0.00086365273,0.002897537,0.0054650824,0.0034607616,0.0025644116,0.0034207217,0.0015652961],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021459493,0.00008998818,0.0057863495,0.0005667357,0.0000426752,0.00031099515,0.0016313024,0.0007926852,0.0016406535,0.1606239,0.75379795,0.074502155],"study_design_scores_gemma":[0.00012245194,0.000061600724,0.013641958,0.00024806536,0.000029619474,0.00008547921,0.0005563402,0.0007561048,0.00043239302,0.011692819,0.97232705,0.00004614979],"about_ca_topic_score_codex":0.9493171,"about_ca_topic_score_gemma":0.9583253,"teacher_disagreement_score":0.9910931,"about_ca_system_score_codex":0.0910354,"about_ca_system_score_gemma":0.35900366,"threshold_uncertainty_score":0.66051114},"labels":[],"label_agreement":null},{"id":"W2145272108","doi":"10.5912/jcb408","title":"Solid organ xenotransplantation: Progress, promise and regulatory issues","year":2001,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Xenotransplantation; Immunosuppression; Immune system; Immunology; Organ transplantation; Transplantation; Biology; Population; Medicine; Environmental health; Internal medicine","score_opus":0.014198992702565066,"score_gpt":0.33058382333065617,"score_spread":0.3163848306280911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145272108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021452245,0.8163057,0.0029976668,0.16490401,0.0055608465,0.00003387423,0.00018108854,0.000109446475,0.007762102],"genre_scores_gemma":[0.029761389,0.8947404,0.0069236043,0.052255355,0.01226356,0.00014323948,0.00040698022,0.00007273298,0.003432763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960522,0.0012510394,0.00034923275,0.0004673596,0.0015072969,0.0003728922],"domain_scores_gemma":[0.9782747,0.011074394,0.0015257715,0.00083893636,0.005844748,0.0024414172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024682952,0.00081177114,0.0015583275,0.0010130419,0.0010948349,0.006707316,0.0023888543,0.00791244,0.006795298],"category_scores_gemma":[0.0137563655,0.00031335824,0.0010086169,0.0016046384,0.0053379163,0.01225063,0.002266648,0.010074286,0.0023837606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053632096,0.00040755724,0.0010320166,0.0038023454,0.00005387598,0.00053990347,0.0003779158,0.0008959391,0.0035515397,0.12155997,0.123015426,0.7442272],"study_design_scores_gemma":[0.00012469482,0.0007471942,0.0011079097,0.0054758694,0.00006787245,0.0009333071,0.00090355513,0.00078471506,0.0017238914,0.08236685,0.90569353,0.00007058446],"about_ca_topic_score_codex":0.0011108742,"about_ca_topic_score_gemma":0.001243307,"teacher_disagreement_score":0.024682952,"about_ca_system_score_codex":0.0020380148,"about_ca_system_score_gemma":0.00816774,"threshold_uncertainty_score":0.13053751},"labels":[],"label_agreement":null},{"id":"W2515152034","doi":"10.5912/jcb749","title":"The BIEM Verification Study: Experienced Venture Capitalists Assess a Biopharmaceuticals Innovation Expertise Model","year":2016,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Venture capital; Biopharmaceutical; Investment (military); Intellectual property; Business; Order (exchange); Sample (material); Marketing; Economics; Industrial organization; Finance; Computer science; Biotechnology; Political science","score_opus":0.0560629197665981,"score_gpt":0.36381064964908283,"score_spread":0.3077477298824847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515152034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854315,0.00016735501,0.0027738116,0.00037750718,0.000059195525,0.0007284744,0.00035825628,0.000022313,0.010081629],"genre_scores_gemma":[0.9941949,0.000051548443,0.002220212,0.00024108954,0.000045048175,0.00075733557,0.00042533653,0.00001694549,0.0020476063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895271,0.006811525,0.0005725083,0.00065096864,0.0015161673,0.00092183315],"domain_scores_gemma":[0.911648,0.04993855,0.016923923,0.005768384,0.009101286,0.0066199773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03426544,0.0006534334,0.0006129649,0.0029414,0.0017038123,0.002734724,0.0012580911,0.0014644384,0.0076617263],"category_scores_gemma":[0.08376531,0.0004140524,0.00074562815,0.0011734924,0.0017677593,0.0049815937,0.004505781,0.0023050813,0.0019682485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059478083,0.008460997,0.8546825,0.00029281175,0.000231164,0.00052361726,0.013060039,0.0022606715,0.0010284092,0.0138514945,0.010431529,0.08922885],"study_design_scores_gemma":[0.0019648098,0.021288602,0.8581505,0.0005354373,0.00017814522,0.0010755227,0.03155593,0.03527672,0.003454231,0.01355653,0.03272231,0.00024120268],"about_ca_topic_score_codex":0.0015148527,"about_ca_topic_score_gemma":0.001969353,"teacher_disagreement_score":0.03426544,"about_ca_system_score_codex":0.0014330723,"about_ca_system_score_gemma":0.001985353,"threshold_uncertainty_score":0.18121517},"labels":[],"label_agreement":null},{"id":"W2897282897","doi":"10.5912/jcb831","title":"Patenting Bioinformatic Inventions: Global Perspective","year":2018,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Patentability; Patentable subject matter; Subject matter; Subject (documents); European patent office; Perspective (graphical); Biotechnology; Engineering; Computer science; Business; Intellectual property; Biology; Political science; Patent law; Law; International trade; World Wide Web; Artificial intelligence","score_opus":0.02433703132021235,"score_gpt":0.32243443082119083,"score_spread":0.29809739950097847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897282897","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027103031,0.16846876,0.05373936,0.12263464,0.0021960055,0.00006989558,0.0009373783,0.00031356246,0.6245374],"genre_scores_gemma":[0.6795723,0.22108616,0.023255063,0.024696883,0.009405202,0.00015385891,0.0009131253,0.0003000707,0.04061736],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9950923,0.0013758441,0.00034930167,0.0014767334,0.0012003434,0.00050539814],"domain_scores_gemma":[0.97481424,0.015833218,0.0021822557,0.0022816602,0.00383614,0.00105249],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0081754355,0.00074758974,0.0009733179,0.009049208,0.0028319156,0.014960338,0.0013733951,0.005159356,0.015438398],"category_scores_gemma":[0.017694097,0.00038327204,0.000825744,0.007823273,0.010484806,0.018551903,0.0038209665,0.006651193,0.0022836775],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023250557,0.000026855952,0.0014289898,0.0003188282,0.000028335257,0.00022815807,0.0005843804,0.0005580663,0.00029846068,0.90730274,0.010437672,0.07876436],"study_design_scores_gemma":[0.000013006898,0.00009132182,0.006231029,0.0011918797,0.000072998606,0.0011167369,0.0013147965,0.0010800966,0.00081929186,0.5186962,0.4693192,0.000053545988],"about_ca_topic_score_codex":0.001964983,"about_ca_topic_score_gemma":0.0011131624,"teacher_disagreement_score":0.99716806,"about_ca_system_score_codex":0.0038125215,"about_ca_system_score_gemma":0.003093654,"threshold_uncertainty_score":0.05164659},"labels":[],"label_agreement":null},{"id":"W4230780364","doi":"10.5912/jcb235","title":"Risk management for the biotechnology industry: A Canadian perspective","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk management; Business; New product development; Strategic planning; Order (exchange); Position (finance); Corporate governance; Enterprise risk management; Product (mathematics); Market risk; Profit (economics); Industrial organization; Marketing; Finance; Economics","score_opus":0.0166169519568604,"score_gpt":0.27076712544454595,"score_spread":0.25415017348768554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230780364","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023101743,0.10403391,0.014139624,0.5067223,0.0017704476,0.00012091257,0.0004900685,0.0001267518,0.34949434],"genre_scores_gemma":[0.66331303,0.19168426,0.022026569,0.0314522,0.0012191532,0.00007790977,0.00034282688,0.00010195517,0.08978215],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99513763,0.00089532055,0.00017383715,0.00034397445,0.0024235426,0.0010257903],"domain_scores_gemma":[0.9920048,0.0014287324,0.00047437774,0.00015275943,0.00435452,0.0015848206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004499843,0.0010460295,0.00054405484,0.004694657,0.010759253,0.011001378,0.002422061,0.004036745,0.005602723],"category_scores_gemma":[0.007496103,0.00039793664,0.0009168054,0.0044321823,0.008345259,0.0038674194,0.0024747576,0.0042735673,0.0004872088],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000569121,0.00009214218,0.006011429,0.0005548613,0.000042114334,0.0010417472,0.008482834,0.0072047524,0.000861076,0.7858921,0.094658345,0.09510149],"study_design_scores_gemma":[0.000023033648,0.000063484134,0.010591746,0.0014335702,0.000082432634,0.00068365206,0.01575517,0.006426608,0.0006733685,0.153594,0.8104568,0.00021619185],"about_ca_topic_score_codex":0.9749094,"about_ca_topic_score_gemma":0.9716086,"teacher_disagreement_score":0.82538307,"about_ca_system_score_codex":0.17461695,"about_ca_system_score_gemma":0.23782103,"threshold_uncertainty_score":0.95732737},"labels":[],"label_agreement":null},{"id":"W4242147379","doi":"10.5912/jcb249","title":"Networks of dedicated biotechnology and service firms in Vancouver","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation and Knowledge Management","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Embeddedness; Competitor analysis; Service (business); Business; Key (lock); Industrial organization; Network structure; Economic geography; Marketing; Economics; Computer science; Sociology","score_opus":0.01737890348448996,"score_gpt":0.22048751931760632,"score_spread":0.20310861583311637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242147379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989277,0.00039309773,0.00015763163,0.00030714966,0.000003795567,0.000031964028,0.00041236085,0.0000075985254,0.009409452],"genre_scores_gemma":[0.99471635,0.00042401714,0.00018317068,0.000043915,0.0000013907248,0.0000144369915,0.00039425018,0.0000030034728,0.0042195763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990563,0.00013894099,0.00003604874,0.00014741524,0.00025142365,0.00036984912],"domain_scores_gemma":[0.9970811,0.00049060537,0.00045151537,0.00008396639,0.0009155634,0.000977104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046744943,0.00014902906,0.00023684901,0.0026634943,0.0035877712,0.00255743,0.00072344317,0.0005454583,0.0034879078],"category_scores_gemma":[0.0038954497,0.00026294985,0.000096281736,0.0057155113,0.0010616867,0.0007042563,0.0024525847,0.0002823825,0.00037973808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041297343,0.00012928715,0.8459419,0.00021072131,0.000060658454,0.0019964864,0.043010913,0.0030808637,0.002808992,0.009280168,0.0053723454,0.08769471],"study_design_scores_gemma":[0.000027478416,0.00006121106,0.8942978,0.00010566554,0.000027231625,0.00047283852,0.07396516,0.0031721664,0.00062412303,0.001185885,0.02601284,0.00004759563],"about_ca_topic_score_codex":0.94252807,"about_ca_topic_score_gemma":0.96512425,"teacher_disagreement_score":0.05747193,"about_ca_system_score_codex":0.0176566,"about_ca_system_score_gemma":0.0125536,"threshold_uncertainty_score":0.1281082},"labels":[],"label_agreement":null},{"id":"W4242946094","doi":"10.1057/palgrave.jcb.3040180","title":"Legal and regulatory update","year":2006,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Investor relations; Business; Law and economics; Strategic management; Economics; Marketing","score_opus":0.007729958218176922,"score_gpt":0.2611671433256631,"score_spread":0.2534371851074862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242946094","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018657307,0.01666831,0.0021466569,0.1663185,0.08118842,0.00064880657,0.0071565635,0.002274978,0.72173214],"genre_scores_gemma":[0.010472921,0.008918982,0.005397014,0.13902423,0.021805584,0.0007124021,0.0063468073,0.00053595175,0.80678606],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9865144,0.0012913456,0.0011040561,0.0009298832,0.008972327,0.0011880848],"domain_scores_gemma":[0.9602633,0.007732971,0.0011023527,0.0027569074,0.026313877,0.0018305877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010177071,0.0008562167,0.0012725845,0.0073799244,0.004593192,0.009414968,0.0038375934,0.017764699,0.07629197],"category_scores_gemma":[0.041638907,0.0007080451,0.0019197371,0.0044745165,0.0020886231,0.0044369865,0.0023867346,0.011796228,0.05017824],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001378335,0.00003540946,0.000104208775,0.0001286718,0.0000043549126,0.000117865064,0.00009269377,0.000063617095,0.00014864554,0.007733135,0.966938,0.02461956],"study_design_scores_gemma":[0.0000036049357,0.000007592448,0.00031012777,0.00016155609,0.0000061441388,0.000050024788,0.00003480676,0.0000254531,0.00007174281,0.0006732088,0.99864906,0.0000066792336],"about_ca_topic_score_codex":0.04394133,"about_ca_topic_score_gemma":0.06367648,"teacher_disagreement_score":0.07629197,"about_ca_system_score_codex":0.007988924,"about_ca_system_score_gemma":0.022136593,"threshold_uncertainty_score":0.25522208},"labels":[],"label_agreement":null},{"id":"W4246549027","doi":"10.5912/jcb246","title":"A comparison of R&D indicators for the Vancouver biotechnology cluster","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Administrative Sciences Association of Canada; Simon Fraser University","funders":"Industry Canada; Government of Canada; Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS)","keywords":"Revenue; Investor relations; Intellectual property; Biotechnology; Cluster (spacecraft); Value (mathematics); Variety (cybernetics); Business; Bioethics; Economics; Marketing; Biology; Strategic management; Political science; Accounting; Law; Computer science","score_opus":0.08105818552773462,"score_gpt":0.3141772405014212,"score_spread":0.23311905497368657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246549027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9365684,0.0009850324,0.0014110119,0.00054218963,0.000014670467,0.00013356995,0.0086863255,0.00010864298,0.051550336],"genre_scores_gemma":[0.9872994,0.000456331,0.001205258,0.00002988797,0.000004320986,0.000039053073,0.0057993624,0.000023106759,0.0051433337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973035,0.00031527193,0.0001666088,0.00024199748,0.0014698621,0.0005029124],"domain_scores_gemma":[0.9846444,0.0022452585,0.0021759914,0.0007059126,0.008438804,0.0017896229],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.0015307415,0.00032074534,0.0004421957,0.011376041,0.00095189235,0.0035946837,0.00076599047,0.00033293484,0.0020885754],"category_scores_gemma":[0.011105411,0.00022150823,0.00025489824,0.02058496,0.000750516,0.0005987666,0.0022793403,0.0005170881,0.000389003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005206791,0.00006454159,0.91036063,0.0002528603,0.00015505377,0.00023814407,0.0017524897,0.006947673,0.0015034514,0.008120794,0.004729861,0.06535392],"study_design_scores_gemma":[0.000013536621,0.000044005752,0.983904,0.000030105171,0.000022780427,0.00005048326,0.002136313,0.0019989067,0.0007468425,0.0004886409,0.010540377,0.000023962551],"about_ca_topic_score_codex":0.7368471,"about_ca_topic_score_gemma":0.839154,"teacher_disagreement_score":0.988624,"about_ca_system_score_codex":0.014976447,"about_ca_system_score_gemma":0.010832874,"threshold_uncertainty_score":0.5294053},"labels":[],"label_agreement":null},{"id":"W4292522193","doi":"10.5912/jcb1299","title":"Impact of information technology on accounting and finance in the digital health sector","year":2022,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"FinTech, Crowdfunding, Digital Finance","field":"Business, Management and Accounting","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Accounting; Descriptive statistics; Finance; Business; Accounting information system; Return on equity; Return on assets; Information technology; Financial accounting; Economics; Profitability index; Computer science; Statistics","score_opus":0.011310659880379806,"score_gpt":0.24839820096948814,"score_spread":0.23708754108910834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292522193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9300765,0.003744872,0.00053308904,0.0044663846,0.00006427647,0.000044371267,0.00029995554,0.000025760475,0.0607448],"genre_scores_gemma":[0.9969349,0.0013530565,0.00023321334,0.00014755325,0.000039636605,0.000004957948,0.00005296458,0.0000023575747,0.0012312867],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966949,0.0014492816,0.00018543904,0.00013537207,0.0009421333,0.00059292355],"domain_scores_gemma":[0.97667706,0.013567383,0.0051465514,0.0006235142,0.00237789,0.0016076311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020546166,0.00015798997,0.00013216026,0.002627377,0.00084170344,0.0041769706,0.0002295393,0.00043661107,0.0062269964],"category_scores_gemma":[0.01371038,0.0000923702,0.00032496642,0.0040572174,0.0010614526,0.002046049,0.0014754744,0.00065516034,0.0006003587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002049016,0.00045374554,0.8017164,0.00032936368,0.000080152815,0.0010899805,0.0030094823,0.001424001,0.0010200565,0.01284937,0.0033822097,0.17444031],"study_design_scores_gemma":[0.000014198082,0.00028748403,0.9564994,0.0004143795,0.00010247968,0.0009158477,0.012299112,0.0021562392,0.0018502459,0.0028479518,0.022579761,0.00003288098],"about_ca_topic_score_codex":0.0076795546,"about_ca_topic_score_gemma":0.008123582,"teacher_disagreement_score":0.0076795546,"about_ca_system_score_codex":0.0028447448,"about_ca_system_score_gemma":0.00330335,"threshold_uncertainty_score":0.020831347},"labels":[],"label_agreement":null},{"id":"W4294315141","doi":"10.5912/jcb1063","title":"Offline Digital Education for Post Registration Health Professions;systematic review by the Digital Health Education Collaboration","year":2022,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Foreign Language Teaching Methods","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Massive open online course; Embodied cognition; Reading (process); Observational study; Online and offline; Medical education; Psychology; Value (mathematics); Digital health; Higher education; Computer science; Outcome (game theory); Mathematics education; Knowledge management; Medicine; Health care; Artificial intelligence; Political science","score_opus":0.02259135419439102,"score_gpt":0.40764695016737984,"score_spread":0.38505559597298883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294315141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002354384,0.99358845,0.00051860674,0.00042608177,0.00022525275,0.0018413062,0.0005796157,0.000023960894,0.00044219763],"genre_scores_gemma":[0.042047627,0.94524246,0.0039463695,0.0012624932,0.00016160097,0.0062720035,0.00050936785,0.000016572194,0.0005415451],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9854155,0.0057828184,0.0048982287,0.0010087661,0.0025634244,0.00033123544],"domain_scores_gemma":[0.9547482,0.030156022,0.009205378,0.0015343532,0.0038023351,0.00055376167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016710775,0.0013311425,0.0050111236,0.017881,0.0008640465,0.0030107757,0.0012803833,0.0016448145,0.004215564],"category_scores_gemma":[0.07392533,0.0008953439,0.0061927084,0.013266838,0.0011607457,0.0030032948,0.002020365,0.0012233317,0.00034000364],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025372326,0.00004430863,0.0009329138,0.92734295,0.006591228,0.00009198576,0.00039768295,0.00009245841,0.00021475708,0.00038284258,0.0022009923,0.061454244],"study_design_scores_gemma":[0.0005656271,0.0003502461,0.0053966837,0.90389174,0.05732412,0.00038476146,0.0008428531,0.00014005115,0.00043842077,0.0006279842,0.029982304,0.000055209646],"about_ca_topic_score_codex":0.010487251,"about_ca_topic_score_gemma":0.029483084,"teacher_disagreement_score":0.017881,"about_ca_system_score_codex":0.004812086,"about_ca_system_score_gemma":0.025600148,"threshold_uncertainty_score":0.088376045},"labels":[],"label_agreement":null}]}